News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development



4/25/2013 6:53:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ZURICH, April 25, 2013 /PRNewswire/ --

- Phase 2b clinical trial of CYT003 in allergic asthma on-going as planned

- Cytos' VLP platform is basis for a phase 1 clinical trial with an Anti-lgE Vaccine partnered with and conducted by Pfizer

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES